A new Northwestern Medicine study has identified the molecular mechanisms that cause a commonly prescribed antipsychotic drug ...

A groundbreaking new study has found that a popular drug can help relieve symptoms of Parkinson’s disease. It’s a fun one, ...

Parkinson’s can cause a wide range ... Our brain cells (called neurons) release chemical messengers called neurotransmitters. One of them is dopamine. This chemical is associated with many ...

The treatment involved creating nerve cells (neurons) derived from embryonic stem cells and transplanting them into the brains of 12 Parkinson’s patients. The injected cells produce a chemical called ...

Until now, levodopa has been the standard first-line treatment for Parkinson’s patients. Levodopa — which is converted into dopamine in the brain and targets the D2/D3/D4 dopamine receptors ...

In more serious cases like Parkinson's disease, dopamine levels drop significantly ... Your gut microbiome produces dopamine and other neurotransmitters in your gut, so supplementing with probiotics ...

A pioneering clinical trial in Japan reveals that stem cell-derived dopamine neurons can survive, function, and boost movement in Parkinson’s patients, without triggering serious side effects or ...

Dopamine and serotonin are both neurotransmitters — chemical messengers ... Insufficient levels of dopamine may be related to depression or Parkinson's disease. Quick tip: For more information ...

AND THIS RESULTS IN A LACK OF A CHEMICAL CALLED DOPAMINE, THUS RESULTING IN THE TYPICAL SIGNS AND SYMPTOMS OF PARKINSON’S DISEASE. AND DOPAMINE, I THINK IS SOMETHING THAT THAT WE’VE ALL ...

Tavapadon, a selective D1/D5 partial dopamine agonist, when used as an adjunct to levodopa, increases daily ON time in Parkinson's patients with motor fluctuations compared to placebo.

At the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases ... of the substantia nigra pars compacta (SNpc), which reduces the levels of dopamine available for ...